Hello, Fool! | Login | Signup | My Fool
Dec 5, 2008 2:08 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.
View All Commentary (AMLN)
Recs
SqwiiToN (< 20) Submitted: 8/28/08 8:38 AM : Start Price: $21.21 AMLN Score: -30.05
oversold on SF
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK